General Insurance

Seattle Cancer Center Opens Latest Mesothelioma Clinical TrialThe Seattle Tumor Care Collusion has opened a stage II clinical trial including durvalumab, the promising immunotherapy medicate, in mix with chemotherapy for the main line treatment of unresectable pleural mesothelioma. The U.S. Nourishment and Medication Organization (FDA) officially conceded...